ZENSARTECH Zensar Technologies Q3 FY26 results (Oct–Dec 2025) and concall
Zensar Technologies reported a modest yet resilient Q3 FY26 with revenue of $160.5 million, growing 2.2% YoY in reported currency, despite sequential degrowth. Profitability metrics were strong, with EBITDA at 17.4% (up 200 bps QoQ) and dollar profit growth of 18.2% YoY, driven by offshore mix and operational efficiencies. The company maintained a healthy order book of $180.2 million and strong cash position, while navigating continued softness in the TMT and Life Sciences verticals.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 7.9%, net profit up 25.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 1,308 | 1,326 | 1,359 | 1,385 | 1,421 +9% | 1,431 +8% |
| EBITDA | 201 | 207 | 212 | 211 | 220 +9% | 250 +21% |
| Net profit | 156 | 160 | 176 | 182 | 182 +17% | 200 +25% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
